Pharmaceutical company Hoffmann-La Roche Inc. was hit on May 29 with a $2.6-million jury verdict over its acne treatment Accutane, the first such verdict in a case that blamed the drug for inflammatory bowel disorder rather than other, more well-known side effects, lawyers say.